Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Insmed
INSM
$27B
| $22.4M | ﹤0.01% |
323,735
-12,827
| -4% | -$924K |
|
2027
Home BancShares
HOMB
$6.28B
| $22.3M | ﹤0.01% |
788,983
+45,187
| +6% | +$1.3M |
|
2028
Crown Holdings
CCK
$12.9B
| $22.3M | ﹤0.01% |
269,917
-49,043
| -15% | -$4.46M |
|
2029
CALL
Builders FirstSource
BLDR
$7.8B
| $22.3M | ﹤0.01% |
156,100
-13,600
| -8% | -$2.41M |
|
2030
CALL
Applied Optoelectronics
AAOI
$12.7B
| $22.3M | ﹤0.01% |
604,100
+165,500
| +38% | +$4.45M |
|
2031
Castle Biosciences
CSTL
$905M
| $22.2M | ﹤0.01% |
834,512
+201,496
| +32% | +$6.14M |
|
2032
CALL
Takeda Pharmaceutical
TAK
$56.3B
| $22.2M | ﹤0.01% |
1,679,400
-16,000
| -0.9% | -$220K |
|
2033
CALL
Enovix
ENVX
$958M
| $22.2M | ﹤0.01% |
2,337,143
-427,543
| -15% | -$3.75M |
|
2034
PUT
CoStar Group
CSGP
$13.1B
| $22.2M | ﹤0.01% |
309,900
+200,600
| +184% | +$15.1M |
|
2035
CALL
Direxion Daily NVDA Bull 2X ETF
NVDU
$636M
| $22.2M | ﹤0.01% |
237,000
+3,600
| +2% | +$411K |
|
2036
CALL
Doximity
DOCS
$4.42B
| $22.2M | ﹤0.01% |
415,300
+67,400
| +19% | +$3.3M |
|
2037
Lemonade
LMND
$4.07B
| $22.1M | ﹤0.01% |
603,132
-408,616
| -40% | -$13M |
|
2038
CALL
Old Dominion Freight Line
ODFL
$43.7B
| $22.1M | ﹤0.01% |
125,300
-101,200
| -45% | -$20.6M |
|
2039
Weyerhaeuser
WY
$17.7B
| $22.1M | ﹤0.01% |
784,396
+294,949
| +60% | +$9.2M |
|
|
2040
Enovix
ENVX
$958M
| $22M | ﹤0.01% |
2,317,583
+1,579,808
| +214% | +$13.9M |
|
2041
CALL
Ciena
CIEN
$60.7B
| $22M | ﹤0.01% |
259,500
+69,500
| +37% | +$4.99M |
|
2042
Talos Energy
TALO
$2.63B
| $22M | ﹤0.01% |
2,264,669
+2,166,257
| +2,201% | +$22.8M |
|
2043
PUT
Huntington Ingalls Industries
HII
$12.9B
| $22M | ﹤0.01% |
116,300
+73,900
| +174% | +$16M |
|
2044
PUT
AGNC Investment
AGNC
$13B
| $21.9M | ﹤0.01% |
2,376,800
+1,093,900
| +85% | +$10.7M |
|
2045
Phillips 66
PSX
$93.2B
| $21.9M | ﹤0.01% |
191,939
-690,639
| -78% | -$87.9M |
|
2046
CALL
Kraft Heinz
KHC
$30.3B
| $21.8M | ﹤0.01% |
710,700
-1,820,100
| -72% | -$59.6M |
|
2047
Global X Uranium ETF
URA
$6.27B
| $21.8M | ﹤0.01% |
814,769
-292,235
| -26% | -$8.94M |
|
2048
CALL
Johnson Controls International
JCI
$93.1B
| $21.8M | ﹤0.01% |
276,400
-416,500
| -60% | -$33.4M |
|
2049
CALL
Ally Financial
ALLY
$13.7B
| $21.8M | ﹤0.01% |
605,800
-76,200
| -11% | -$2.77M |
|
2050
PUT
AES
AES
$10.5B
| $21.8M | ﹤0.01% |
1,693,700
+1,088,600
| +180% | +$16.3M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.